Kailash Singhvi, MD
Gastroenterology · East Brunswick, NJNPI 1972701563
Payments from drug & device makers
Across 113 payments — averaging $43.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Merz North America, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$455
- Johnson & Johnson$419
- Bristol Myers Squibb$379
- Silk Road Medical, Inc.$122
- plus $238 from 7 others
What the payments were for
- Food & beverage$4,85798%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $1,852 |
| Merz North America, Inc. | 25 | $1,492 |
| E.r. Squibb & Sons, L.L.C. | 4 | $455 |
| Johnson & Johnson | 7 | $419 |
| Bristol Myers Squibb | 31 | $379 |
| Silk Road Medical, Inc. | 1 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Redhill Biopharma Inc. | 5 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Meridian Bioscience Inc. | 1 | $23 |
| Echosens North America, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$625
- Rinvoq$500
- ZEPOSIA$347
- STELARA$250
- XEOMIN$156
- Tremfya$125
- ENROUTE Transcarotid Stent$122
- ENROUTE Transcarotid Neuroprotection System$122
How this compares
$4,956 in reported general payments places this provider in the 65th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 82 | $5,895 |
| Omeprazole | 77 | $1,508 |
| CholestyramineCholestyramine (With Sugar) | 14 | $859 |
| Pantoprazole Sodium | 22 | $480 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $373 |
| Sucralfate | 16 | $342 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $311 |
| Dicyclomine Hcl | 11 | $138 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in East Brunswick
- Kiran RaoSparta$1.3M
- Adekunle AdeotiIrvington$1.2M
- Carl WallachMorristown$766K
- Vinod RustgiNew Brunswick$697K
- Arvind TrindadeNew Brunswick$652K
- Barry KaufmanEgg Harbor Township$595K
- Promila BanerjeeStratford$522K
- Neil NagariaToms River$442K
- Zamir BrelviNewark$408K
- Adam ElfantMount Laurel$385K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.